Novo Nordisk is a global healthcare company with a record of 90 years of innovation and leadership in diabetes care. We also have leading positions within haemophilia care, growth hormone treatment and hormone replacement therapy.
Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.
Every day, millions of people all over the world rely on our products, which are manufactured in seven countries.
Over the past 90 years, our researchers have pioneered many breakthroughs in its management, and today, our determination to help these people is stronger than ever.
Novo Nordisk has provided financial support to this event for exhibition space and a sponsored symposium session for which Novo Nordisk are fully responsible.
Stand number: D02